Johnson & Johnson expands roll-out of Tecnis Odyssey IOL
Click Here to Manage Email Alerts
Johnson & Johnson has expanded the roll-out of its presbyopia-correcting, full-visual range Tecnis Odyssey IOL, the company announced in a press release.
“Tecnis Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the U.S. today,” Peter Menziuso, group chairman of vision at Johnson & Johnson, said in the release. “Cataract surgery gives patients a once-in-a-lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”
According to the release, patients fitted with the Tecnis Odyssey IOL are able to read 14% smaller print compared with PanOptix IOL (Alcon) patients, with 93% of Tecnis patients reporting no or mild halos, glare or starbursts 1 month after surgery. In addition, the Tecnis Odyssey IOL provides two-times better contrast than PanOptix in low light, the company stated.
Further, 94% of patients reported being satisfied with their overall vision without glasses, while 97% were satisfied with distance vision, and 92% were satisfied with their ability to see at night, according to the release.
“The Tecnis Odyssey IOL is perhaps the most comprehensive and well-balanced [presbyopia-correcting (PC)]-IOL on the market to date,” George O. Waring IV, MD, FACS, founder and medical director at Waring Vision Institute in Mount Pleasant, South Carolina, said in the release. “It falls under a new standard of full-vision range that provides extraordinary contrast in both day and nighttime conditions, tolerance to refractive error and minimal dysphotopsias with outstanding contrast sensitivity that really takes it to a whole different level and nothing like we’ve seen before with prior PC-IOLs.”
Along with the roll-out, Johnson & Johnson is launching the Tecnis Odyssey IOL Peer Connect initiative, which is designed to facilitate conversations between eye care professionals and expert surgeons who had early access to the technology.
Read more about
Click Here to Manage Email Alerts